Parabilis Medicines Inc.
PBLS | NASDAQ
$27.54
-$0.78 (-2.75%)
Nov 2, 2026, 9:52 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
PE Ratio | -0.22 | -0.24 |
PEG Ratio | -0.02 | n/a |
PS Ratio | n/a | n/a |
PB Ratio | -2.45 | 0.69 |
P/FCF Ratio | -0.33 | -0.37 |
P/OCF Ratio | -0.33 | -0.37 |
OCF/S Ratio | n/a | n/a |
Debt / Equity Ratio | -3.55 | 1.17 |
Quick Ratio | 0.52 | 2.84 |
Current Ratio | 0.52 | 2.84 |
Asset Turnover | n/a | n/a |
Interest Coverage | -99.92 | -84.88 |
Return on Equity | 882.89% | -208.92% |
Return on Assets | -180.51% | -79% |
Return on Invested Capital | -338.57% | -99.93% |
Dividend Yield | n/a | n/a |
Payout Ratio | n/a | n/a |
FCF Payout Ratio | n/a | n/a |
Gross Profit Margin | n/a | n/a |
Net Profit Margin | n/a | n/a |
Pretax Profit Margin | n/a | n/a |
Operating Profit Margin | n/a | n/a |
FCF Margin | n/a | n/a |
EBITDA Margin | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PBLS